Bioresorbable Scaffolds: From Intuition to Evidence | Prof. (Dr.) Ashok Seth

For decades, interventional cardiology has relied on permanent metallic stents to treat coronary artery disease. The concept of leaving nothing behind after the vessel has healed has always been intuitively appealing, but the real question was whether clinical evidence would support that vision.
In this discussion, I reflect on the evolution of bioresorbable scaffold technology and why robust randomized data represents a major step forward. As operators, we learned the importance of meticulous technique with metallic stents. The same principles remain critical with newer scaffold technologies. When used appropriately and implanted well, these devices offer the potential to restore the vessel while avoiding a permanent implant.
Innovation succeeds when sound science, evidence, and technique come together.

#DrAshokSeth #BioresorbableScaffold #InterventionalCardiology #CoronaryArteryDisease #PCI #MedicalInnovation

Dr Ashok Seth, bioresorbable scaffold, BRS technology, coronary artery disease, PCI, interventional cardiology, randomized trial data

For Appointment or Consultation : -
Fortis Escorts Heart Institute & Research Centre, Okhla Road, New Delhi - 110025 (INDIA)
Ph : - 011 - 47135000, 011 - 26825013
=================================================================
Stay Connected:
Twitter - twitter.com/Dr_AshokSeth
Linkedin - linkedin.com/in/drashokseth
Facebook - facebook.com/DrAshokSeth.HM
Instagram - instagram.com/dr_ashokseth

#HeartHealth #CardiologistTips #HeartAttackPrevention #HealthyHeart